See also this year's filing and all EDGAR filings for this company.
PDF Report 0000827871_2023_Eagle_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0000827871, Eagle Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 188,754,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 163,360,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,168,000 |
| 3 | remainder_Assets | 52,878,000 |
| 4 | LiabilitiesCurrent | 111,087,000 |
| 5 | LiabilitiesNoncurrent | 61,513,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 81,984,616 |
| 8 | SellingGeneralAndAdministrativeExpense | 124,735,792 |
| 9 | ResearchAndDevelopmentExpense | 37,970,130 |
| 10 | remainder_Expenses | 32,629,223 |
| 11 | remainder_Revenues | 450,666,850 |
| 12 | remainder_NetIncome | -12,894,465 |
| 13 | remainder_ComprehensiveNetIncome | -5,638,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 406,160,000 |
| 1 | Liabilities | 172,600,000 |
| 2 | Expenses | 277,319,761 |
| 3 | Revenues | 450,666,850 |
| 4 | StockholdersEquity | 233,560,000 |
| 5 | NetIncome | 160,452,624 |
| 6 | ComprehensiveNetIncome | 157,633,624 |
| 7 | BaseVar | 662,639,538 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.30 |
| 9 | EconomicCapitalRatio | 3.23 |
Edgar->Model Mapping
Feature Distribution
Change over Time
